AnaptysBio Files 8-K for Regulation FD Disclosure
Ticker: ANAB · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1370053
| Field | Detail |
|---|---|
| Company | Anaptysbio, Inc (ANAB) |
| Form Type | 8-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: ANAB
TL;DR
ANAB filed an 8-K for a Reg FD disclosure, no new material info detailed.
AI Summary
AnaptysBio, Inc. filed an 8-K on February 19, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.
Why It Matters
This filing indicates AnaptysBio is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain new material information that would immediately impact the company's stock price.
Key Players & Entities
- ANAPTYSBIO, INC (company) — Registrant
- February 19, 2025 (date) — Date of Report
- Regulation FD (regulation) — Type of Disclosure
- Delaware (jurisdiction) — State of Incorporation
- 10770 Wateridge Circle, Suite 210, San Diego, CA 92121 (address) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is to report a Regulation FD Disclosure.
What is the exact name of the registrant?
The exact name of the registrant is ANAPTYSBIO, INC.
In which state was AnaptysBio, Inc. incorporated?
AnaptysBio, Inc. was incorporated in Delaware.
What is the address of AnaptysBio, Inc.'s principal executive offices?
The address of AnaptysBio, Inc.'s principal executive offices is 10770 Wateridge Circle, Suite 210, San Diego, CA 92121.
What is the telephone number for AnaptysBio, Inc.?
The telephone number for AnaptysBio, Inc. is (858) 362-6295.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding ANAPTYSBIO, INC (ANAB).